SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report
(Date of earliest event reported): July 27, 2004
ARIAD PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-21696 22-3106987
- ---------------------------- ----------------------- ------------------
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
26 LANDSDOWNE STREET
CAMBRIDGE, MASSACHUSETTS 02139
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code:
(617) 494-0400
ITEM 5. OTHER EVENTS
On July 27, 2004, the Registrant disseminated a Press Release announcing that it
will provide a live webcast of its corporate presentation at the Adams Harkness
24th Annual Summer Seminar on Tuesday, August 3, 2004, at the Marriott Long
Wharf Hotel in Boston. The presentation will be given at 2 p.m. (ET) by Harvey
J. Berger, M.D., chairman and chief executive officer of ARIAD, who will provide
an overview of the Company and its progress in key programs.
The information contained in the Press Release dated July 27, 2004, is
incorporated herein by reference and attached as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
99.1 The Registrant's Press Release dated July 27, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ARIAD PHARMACEUTICALS, INC.
By: /s/ Edward M. Fitzgerald
----------------------------------
Edward M. Fitzgerald
Senior Vice President and
Chief Financial Officer
Date: July 27, 2004
2
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number
- -------- ----------- -----------
99.1 The Registrant's Press Release dated July 27, 2004. 4
3